Menu

Filtros : "DIABETES MELLITUS" "Hospital de Clinicas de Porto Alegre Research Incentive Fund (FIPE-HCPA), Porto Alegre, Brazil" Removidos: "ZATZ, MAYANA" "scu" Limpar

Filtros

Refine with date range

  • 1

1 - 2 (2 records)

  • Artigo de periodico

    Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future (2022)

    Ferrari, Filipe; Scheffel, Rafael S.; Martins, Vitor M.; Santos Filho, Raul Dias dos ; Stein, Ricardo

    Source: American journal of cardiovascular drugs. Unidade: FM

    Subjects: DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES, FATORES DE RISCO

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      FERRARI, Filipe et al. Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future. American journal of cardiovascular drugs, v. 22, n. 4, p. 363-383, 2022Tradução . . Disponível em: https://doi.org/10.1007/s40256-021-00515-4. Acesso em: 13 nov. 2024.

    • APA

      Ferrari, F., Scheffel, R. S., Martins, V. M., Santos Filho, R. D. dos, & Stein, R. (2022). Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future. American journal of cardiovascular drugs, 22( 4), 363-383. doi:10.1007/s40256-021-00515-4

    • NLM

      Ferrari F, Scheffel RS, Martins VM, Santos Filho RD dos, Stein R. Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future [Internet]. American journal of cardiovascular drugs. 2022 ; 22( 4): 363-383.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s40256-021-00515-4

    • Vancouver

      Ferrari F, Scheffel RS, Martins VM, Santos Filho RD dos, Stein R. Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future [Internet]. American journal of cardiovascular drugs. 2022 ; 22( 4): 363-383.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1007/s40256-021-00515-4

  • Artigo de periodico

    The role of sodium-glucose cotransporter-2 inhibitors in patients with heart failure, regardless of diabetes status: focus on cardiovascular disease (2021)

    Ferrari, Filipe; Martins, Vitor M; Scheffel, Rafael S; Silveira, Anderson D. da; Motta, Marcelo Trotte; Moriguchi, Emilio H; Santos Filho, Raul Dias dos ; Stein, Ricardo

    Source: Annals of pharmacotherapy. Unidade: FM

    Subjects: INSUFICIÊNCIA CARDÍACA, DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      FERRARI, Filipe et al. The role of sodium-glucose cotransporter-2 inhibitors in patients with heart failure, regardless of diabetes status: focus on cardiovascular disease. Annals of pharmacotherapy, v. 55, n. 10, p. 1267-1275, 2021Tradução . . Disponível em: https://doi.org/10.1177/1060028020985111. Acesso em: 13 nov. 2024.

    • APA

      Ferrari, F., Martins, V. M., Scheffel, R. S., Silveira, A. D. da, Motta, M. T., Moriguchi, E. H., et al. (2021). The role of sodium-glucose cotransporter-2 inhibitors in patients with heart failure, regardless of diabetes status: focus on cardiovascular disease. Annals of pharmacotherapy, 55( 10), 1267-1275. doi:10.1177/1060028020985111

    • NLM

      Ferrari F, Martins VM, Scheffel RS, Silveira AD da, Motta MT, Moriguchi EH, Santos Filho RD dos, Stein R. The role of sodium-glucose cotransporter-2 inhibitors in patients with heart failure, regardless of diabetes status: focus on cardiovascular disease [Internet]. Annals of pharmacotherapy. 2021 ; 55( 10): 1267-1275.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1177/1060028020985111

    • Vancouver

      Ferrari F, Martins VM, Scheffel RS, Silveira AD da, Motta MT, Moriguchi EH, Santos Filho RD dos, Stein R. The role of sodium-glucose cotransporter-2 inhibitors in patients with heart failure, regardless of diabetes status: focus on cardiovascular disease [Internet]. Annals of pharmacotherapy. 2021 ; 55( 10): 1267-1275.[citado 2024 nov. 13 ] Available from: https://doi.org/10.1177/1060028020985111
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024